M. Fickers

1.1k total citations
18 papers, 863 citations indexed

About

M. Fickers is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, M. Fickers has authored 18 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in M. Fickers's work include Lymphoma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). M. Fickers is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). M. Fickers collaborates with scholars based in Netherlands, United States and France. M. Fickers's co-authors include J. Wils, D. J. Th. Wagener, Serge Leyvraz, Harry Bleiberg, H. E. Reis, T. Conroy, Marc Buyse, H. O. Klein, F.W. Korsten and Hanneke C. Kluin‐Nelemans and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Clinical Chemistry.

In The Last Decade

M. Fickers

18 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Fickers Netherlands 11 355 322 294 277 262 18 863
C. Martin France 9 365 1.0× 73 0.2× 380 1.3× 352 1.3× 130 0.5× 13 894
Marcel Hayat France 12 135 0.4× 97 0.3× 264 0.9× 160 0.6× 82 0.3× 20 579
Carla Pieresca Italy 11 131 0.4× 148 0.5× 362 1.2× 188 0.7× 80 0.3× 23 489
Marlene Troch Austria 15 150 0.4× 181 0.6× 638 2.2× 337 1.2× 149 0.6× 32 779
Heidi D. Finnes United States 15 233 0.7× 305 0.9× 198 0.7× 693 2.5× 112 0.4× 37 1.0k
Lorella Orsucci Italy 15 82 0.2× 441 1.4× 713 2.4× 356 1.3× 243 0.9× 45 892
Mariapaola Fina Italy 12 223 0.6× 111 0.3× 755 2.6× 287 1.0× 169 0.6× 30 948
Christian W. Scholz Germany 12 156 0.4× 140 0.4× 295 1.0× 253 0.9× 120 0.5× 38 544
M. Hoffmann Austria 12 159 0.4× 136 0.4× 518 1.8× 214 0.8× 112 0.4× 20 674
Chueh‐Chuan Yen Taiwan 19 377 1.1× 69 0.2× 173 0.6× 386 1.4× 48 0.2× 58 930

Countries citing papers authored by M. Fickers

Since Specialization
Citations

This map shows the geographic impact of M. Fickers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fickers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fickers more than expected).

Fields of papers citing papers by M. Fickers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Fickers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fickers. The network helps show where M. Fickers may publish in the future.

Co-authorship network of co-authors of M. Fickers

This figure shows the co-authorship network connecting the top 25 collaborators of M. Fickers. A scholar is included among the top collaborators of M. Fickers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Fickers. M. Fickers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schaar, C. G., Hanneke C. Kluin‐Nelemans, Saskia le Cessie, et al.. (2005). Interferon-α as maintenance therapy in patients with multiple myeloma. Annals of Oncology. 16(4). 634–639. 41 indexed citations
2.
Poortmans, Philip, Hanneke C. Kluin‐Nelemans, Hanny Haaxma-Reiche, et al.. (2003). High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. Journal of Clinical Oncology. 21(24). 4483–4488. 233 indexed citations
3.
Kluin‐Nelemans, Hanneke C., P Poortmans, Morten Bagge Hansen, et al.. (2002). Dose MTX-based chemotherapy followed by consolidating radiotherapy in Non-Aids related Primary Central Nervous System Lymphoma.. Data Archiving and Networked Services (DANS). 4 indexed citations
4.
Mook, Walther van, et al.. (2001). Clinical and immunological evaluation of primary splenic irradiation in chronic lymphocytic leukemia: a study of 24 cases. Annals of Hematology. 80(4). 216–223. 7 indexed citations
5.
6.
Peters, Frank, et al.. (2001). Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study. Annals of Hematology. 80(3). 155–159. 37 indexed citations
7.
Fickers, M., et al.. (2001). Paraneoplastic pemphigus as the initial presentation of chronic lymphocytic leukemia. Annals of Oncology. 12(1). 115–118. 22 indexed citations
8.
Peters, Florian, M. Fickers, Frans Erdkamp, et al.. (2001). The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates. Annals of Hematology. 80(7). 406–410. 20 indexed citations
9.
Theunissen, P, et al.. (2001). Primary large cell neuroendocrine carcinoma of the presacral region. Journal of Clinical Pathology. 54(11). 880–882. 12 indexed citations
10.
Fickers, M. & P Theunissen. (1996). Granulocytic sarcoma with expression of CD30.. Journal of Clinical Pathology. 49(9). 762–763. 19 indexed citations
11.
Starmans‐Kool, Mirian, et al.. (1995). An unwanted side effect of hydroxyurea in a patient with idiopathic myelofibrosis. Annals of Hematology. 70(5). 279–280. 5 indexed citations
12.
Wagener, D. J. Th., J. Wils, J Burghouts, et al.. (1993). Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer. Annals of Oncology. 4(5). 426–428. 8 indexed citations
13.
Hupperets, P., Lex Volovics, Leo J. Schouten, et al.. (1993). Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients. Annals of Oncology. 4(4). 295–301. 17 indexed citations
14.
15.
Coenen, J.L., Jos van Pelt, Cees Th.B.M. van Deursen, et al.. (1991). Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease. Clinical Chemistry. 37(4). 560–563. 69 indexed citations
16.
Fickers, M., et al.. (1991). Malignant lymphoma of the testis.. PubMed. 39(1-2). 92–100. 5 indexed citations
17.
Fickers, M. & B Speck. (1974). Thrombocythaemia. Acta Haematologica. 51(5). 257–265. 41 indexed citations
18.
Fickers, M., et al.. (1972). Retrospective study and perspectives in the treatment of meningeal leukaemia.. PubMed. 15(6). 271–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Martin Breakdown of academic impact, for papers by Marcel Hayat Breakdown of academic impact, for papers by Carla Pieresca Breakdown of academic impact, for papers by Marlene Troch Breakdown of academic impact, for papers by Heidi D. Finnes Breakdown of academic impact, for papers by Lorella Orsucci Breakdown of academic impact, for papers by Mariapaola Fina Breakdown of academic impact, for papers by Christian W. Scholz Breakdown of academic impact, for papers by M. Hoffmann Breakdown of academic impact, for papers by Chueh‐Chuan Yen
Rankless by CCL
2026